Johnson Pharmacare Ltd
BSE: 532154
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q4 FY2026 | Q3 FY2026 | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 |
|---|---|---|---|---|---|
| INCOME | |||||
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 1.58 | 0.00 | 0.00 | 0.00+100.0% | -0.33 |
| Total Income | 1.58 | 0.00 | 0.00 | 0.00+100.0% | -0.33 |
| EXPENSES | |||||
| Expenditure | 42.92+66965.0% | 0.06+1782.4% | 0.00-93.6% | 0.05+551.2% | 0.01 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PROFIT | |||||
| PBT | -55.61-86791.6% | -0.06-1782.4% | -0.00+93.6% | -0.05+89.6% | -0.51 |
| Net Profit | -55.61-86791.6% | -0.06-1782.4% | -0.00+93.6% | -0.05+89.6% | -0.51 |
| KEY METRICS | |||||
| NPM % | -100.00% | — | — | — | 100.00% |
| EPS | 1.01 | 0.00 | 0.00 | 0.00-100.0% | 0.01 |
Corporate Events
Board MeetingJOHNPHARMA
202627May
Board Meeting
To consider and approve the Audited Financial Results of the…
BSE Filing ↗